市場調査レポート
商品コード
1105251

人物同定の世界市場 (2022-2032年):提供区分・技術・用途・エンドユーザー・地域別の分析・予測

Human Identification - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and Forecast, 2022-2032

出版日: | 発行: BIS Research | ページ情報: 英文 231 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
人物同定の世界市場 (2022-2032年):提供区分・技術・用途・エンドユーザー・地域別の分析・予測
出版日: 2022年07月08日
発行: BIS Research
ページ情報: 英文 231 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人物同定の市場規模は2021年の13億8,580万米ドルから、予測期間中は14.77%のCAGRで推移し、2032年には64億3,560万米ドルの規模に成長すると予測されています。

さまざまな研究分野におけるNGSの採用拡大、法医学用途での高い採用率、分子技術や診断テストの分野における技術的進歩が同市場の成長を推進する見通しです。

当レポートでは、世界の人物同定の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 市場

第2章 市場範囲

第3章 調査手法

第4章 市場概要

  • 法医学の進化
  • 人物同定へのアプローチ:生物学的アプローチ
  • 世界の人物同定市場
  • COVID-19が世界の人物同定市場に与える影響

第5章 産業考察

  • 規制の枠組み
  • アジア太平洋地域の法的要件と枠組み

第6章 市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第7章 競合考察

  • 企業戦略
  • 事業戦略
  • 市場シェア分析:製品製造業者別
  • 市場シェア分析:サービスプロバイダー別

第8章 世界の人物同定市場:提供区分別

  • 概要
  • 製品
    • アッセイ・キット
    • 機器
    • ソフトウェア
  • サービス

第9章 世界の人物同定市場:技術別

  • 概要
  • 次世代シーケンシング (NGS)
    • SNPおよびSTRシーケンシング
    • mtDNAシーケンシング
  • ポリメラーゼ連鎖反応 (PCR)
    • デジタルPCR
    • リアルタイムPCR
  • キャピラリー電気泳動
  • 核酸抽出・精製(磁気ビーズ技術)
  • 迅速DNA分析技術
  • その他

第10章 世界の人物同定市場:用途別

  • 概要
  • 法医学
    • 犯罪・性的暴行の調査
    • 行方不明者調査
    • 被災者確認
    • その他
  • 父子鑑定
    • 父子鑑定
    • 遺伝子検査
  • その他

第11章 世界の人物同定市場:エンドユーザー別

  • 概要
  • 法医学ラボ・法執行機関
  • 学術・研究機関
  • 病院・ヘルスケア提供者

第12章 世界の人物同定市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第13章 市場:企業プロファイル

  • 概要
  • Abbott.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • Promega Corporation
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Verogen, Inc.
  • NMS Labs
  • AUTOGEN INC.
  • GENETEK BIOPHARMA GmbH
  • SecuriGene Technologies Inc.
図表

List of Figures

  • Figure 1: Sexual Offences in the U.S., 2019-2022
  • Figure 2: NIH Funding, 2019-2022
  • Figure 3: Global Human Identification Market Dynamics
  • Figure 4: Global Human Identification Market (by Offering), $Million, 2021 and 2032
  • Figure 5: Global Human Identification Market (by Application), $Million, 2021 and 2032
  • Figure 6: Global Human Identification Market (by Technology), $Million, 2021 and 2032
  • Figure 7: Global Human Identification Market (by End User), $Million, 2021 and 2032
  • Figure 8: Global Human identification Market (by Region), $Million, 2021
  • Figure 9: Global Human Identification Market: Market Segmentation
  • Figure 10: Global Human Identification Market Research Methodology
  • Figure 11: Primary Research Methodology
  • Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 13: Top-Down Approach (Segment-Wise Analysis)
  • Figure 14: Different Steps in Forensics Technology
  • Figure 15: Evolution in Forensic Investigation
  • Figure 16: Workflow for Forensic Procedures
  • Figure 17: Dominating Segments of the Global Human Identification Market, 2021 and 2032
  • Figure 18: Global Human Identification Market, $Million, 2021-2032
  • Figure 19: Pre-COVID-19 and Post-COVID-19 Scenario of Global Human Identification Market, 2020-2026
  • Figure 20: Impact of COVID-19 on Human Identification Market
  • Figure 21: Responsibilities of the National Medical Products Administration (NMPA)
  • Figure 22: Global Human Identification Market Dynamics
  • Figure 23: Total Violent Crime Reported in the U.S., 2015-2020
  • Figure 24: NIH Funding, 2019-2022
  • Figure 25: Share of Key Developments and Strategies, January 2019-May 2022
  • Figure 26: Synergistic Activities Share (by Company), January 2019-May 2022
  • Figure 27: Service/Product Launches (by Company), January 2019-May 2022
  • Figure 28: Global Human Identification Market Share Analysis (by Product Manufacturer), 2020 and 2021
  • Figure 29: Global Human Identification Market Share Analysis (by Service Provider), 2020 and 2021
  • Figure 30: Global Human Identification Market (by Offering)
  • Figure 31: Share of Global Human Identification Market (by Offering), $Million, 2021 and 2032
  • Figure 32: Share of Global Human Identification Market (by Product), $Million, 2021 and 2032
  • Figure 33: Global Human Identification Market (Product), $Million, 2021-2032
  • Figure 34: Global Human Identification Market (Assay and Kit), $Million, 2021-2032
  • Figure 35: Global Human Identification Market (DNA Amplification Kit), $Million, 2021-2032
  • Figure 36: Global Human Identification Market (DNA Quantification Kit), $Million, 2021-2032
  • Figure 37: Global Human Identification Market (DNA Extraction Kit), $Million, 2021-2032
  • Figure 38: Global Human Identification Market (Rapid DNA Analysis Kit), $Million, 2021-2032
  • Figure 39: Global Human Identification Market (Instrument), $Million, 2021-2032
  • Figure 40: Global Human Identification Market (DNA Collection System), $Million, 2021-2032
  • Figure 41: Global Human Identification Market (Electrophoresis System), $Million, 2021-2032
  • Figure 42: Global Human Identification Market (Thermal Cycler), $Million, 2021-2032
  • Figure 43: Global Human Identification Market (Rapid DNA Analysis System), $Million, 2021-2032
  • Figure 44: Global Human Identification Market (NGS Platform), $Million, 2021-2032
  • Figure 45: Global Human Identification Market (Microarray Scanner), $Million, 2021-2032
  • Figure 46: Global Human Identification Market (Other Instruments), $Million, 2021-2032
  • Figure 47: Global Human Identification Market (Software), $Million, 2021-2032
  • Figure 48: Global Human Identification Market (Analytical Software), $Million, 2021-2032
  • Figure 49: Global Human Identification Market (Data Interpretation), $Million, 2021-2032
  • Figure 50: Global Human Identification Market (Data Storage), $Million, 2021-2032
  • Figure 51: Global Human Identification Market (Service), $Million, 2021-2032
  • Figure 52: Global Human Identification Market (by Technology), $Million, 2021 and 2032
  • Figure 53: Global Human Identification Market (Next-Generation Sequencing), $Million, 2021-2032
  • Figure 54: Global Human Identification Market (SNP and STR Sequencing), $Million, 2021-2032
  • Figure 55: Global Human Identification Market (mtDNA Sequencing), $Million, 2021-2032
  • Figure 56: Application of PCR
  • Figure 57: Global Human Identification Market (Polymerase Chain Reaction), $Million, 2021-2032
  • Figure 58: Global Human Identification Market (Digital PCR), $Million, 2021-2032
  • Figure 59: Global Human Identification Market (Real-Time PCR), $Million, 2021-2032
  • Figure 60: Global Human Identification Market (Capillary Electrophoresis), $Million, 2021-2032
  • Figure 61: Global Human Identification Market Nucleic Acid Extraction and Purification (Magnetic Bead Technology), $Million, 2021-2032
  • Figure 62: Global Human Identification Market (Rapid DNA Analysis Technology), $Million, 2021-2032
  • Figure 63: Global Human Identification Market (Other Technologies), $Million, 2021-2032
  • Figure 64: Global Human Identification Market (by Application)
  • Figure 65: Global Human Identification Market (by Application), $Million, 2021 and 2032
  • Figure 66: Global Human Identification Market (Crime And Sexual Assault Investigation), $Million, 2021-2032
  • Figure 67: Global Human Identification Market (Missing Person Investigation), $Million, 2021-2032
  • Figure 68: Global Human Identification Market (Disaster Victim Identiifcation), $Million, 2021-2032
  • Figure 69: Global Human Identification Market (Others), $Million, 2021-2032
  • Figure 70: Global Human identification Market (Paternity Identification), $Million, 2021-2032
  • Figure 71: Global Human Identification Market (Paternity and Kinship Testing), $Million, 2021-2032
  • Figure 72: Global Human Identification Market (Genetic Testing), $Million, 2021-2032
  • Figure 73: Global Human identification Market (Other Application), $Million, 2021-2032
  • Figure 74: Global Human Identification Market (by End User), 2021 vs. 2032
  • Figure 75: Global Human Identification Market (by Forensic Laboratories and Law enforcement Agencies), $Million, 2021-2032
  • Figure 76: Global Human Identification Market (Academic and Research Institutions), $Million, 2021-2032
  • Figure 77: Global Human Identification Market (Hospitals and Healthcare Providers), $Million, 2021-2032
  • Figure 78: Global Human identification Market (by Region), $Million, 2021-2032
  • Figure 79: North America Human Identification Market (by Country), 2021 vs. 2032
  • Figure 80: North America Human Identification Market, $Million, 2021-2032
  • Figure 81: Market Dynamics of North America Human Identification Market
  • Figure 82: U.S. Human Identification Market, $Million, 2021-2032
  • Figure 83: U.S. Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 84: U.S. Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 85: U.S. Human Identification Market (by Product), $Million, 2021-2032
  • Figure 86: Canada Human Identification Market, $Million, 2021-2032
  • Figure 87: Canada Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 88: Canada Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 89: Canada Human Identification Market (by Product), $Million, 2021-2032
  • Figure 90: Europe Human Identification Market (by Country), 2021 vs. 2032
  • Figure 91: Europe Human Identification Market, $Million, 2021-2032
  • Figure 92: Market Dynamics of the Europe Human identification Market
  • Figure 93: Germany Human Identification Market, 2021-2032
  • Figure 94: Germany Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 95: Germany Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 96: Germany Human Identification Market (by Product), $Million, 2021-2032
  • Figure 97: France Human Identification Market, $Million, 2021-2032
  • Figure 98: France Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 99: France Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 100: France Human Identification Market (by Product), $Million, 2021-2032
  • Figure 101: U.K. Human Identification Market, $Million, 2021-2032
  • Figure 102: Sexual Assault Cases Trends in the U.K
  • Figure 103: U.K. Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 104: U.K. Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 105: U.K. Human Identification Market (by Product), $Million, 2021-2032
  • Figure 106: Italy Human Identification Market, $Million 2021-2032
  • Figure 107: Italy Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 108: Italy Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 109: Italy Human Identification Market (by Product), $Million, 2021-2032
  • Figure 110: Spain Human Identification Market, $Million, 2021-2032
  • Figure 111: Spain Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 112: Spain Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 113: Spain Human Identification Market (by Product), $Million, 2021-2032
  • Figure 114: Rest-of-Europe Human Identification Market, $Million, 2021-2032
  • Figure 115: Rest-of-Europe Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 116: Rest-of-Europe Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 117: Rest-of-Europe Human Identification Market (by Product), $Million, 2021-2032
  • Figure 118: Asia-Pacific Human Identification Market (by Country), 2021 vs. 2032
  • Figure 119: Asia-Pacific Human Identification Market, $Million, 2021-2032
  • Figure 120: Market Dynamics of the Asia-Pacific Human Identification Market
  • Figure 121: China Human Identification Market, $Million, 2021-2032
  • Figure 122: China Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 123: China Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 124: China Human Identification Market (by Product), $Million, 2021-2032
  • Figure 125: Japan Human Identification Market, $Million, 2021-2032
  • Figure 126: Japan Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 127: Japan Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 128: Japan Human Identification Market (by Product), $Million, 2021-2032
  • Figure 129: India Human Identification Market, $Million, 2021-2032
  • Figure 130: India Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 131: India Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 132: India Human Identification Market (by Product), $Million, 2021-2032
  • Figure 133: Australia Human Identification Market, $Million, 2021-2032
  • Figure 134: Australia Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 135: Australia Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 136: Australia Human Identification Market (by Product), $Million, 2021-2032
  • Figure 137: South Korea Human Identification Market, $Million, 2021-2032
  • Figure 138: South Korea Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 139: South Korea Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 140: Australia Human Identification Market (by Product), $Million, 2021-2032
  • Figure 141: Rest-of-Asia-Pacific Human Identification Market, 2021-2032
  • Figure 142: Rest-of-Asia-Pacific Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 143: Rest-of-Asia-Pacific Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 144: Rest-of-Asia-Pacific Human Identification Market (by Product), $Million, 2021-2032
  • Figure 145: Latin America Human Identification Market (by Country), 2021 vs. 2032
  • Figure 146: Latin America Human Identification Market, $Million, 2021-2032
  • Figure 147: Market Dynamics of Latin America Human Identification Market
  • Figure 148: Brazil Human Identification Market, $Million, 2021-2032
  • Figure 149: Brazil Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 150: Brazil Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 151: Brazil Human Identification Market (by Product), $Million, 2021-2032
  • Figure 152: Mexico Human Identification Market, 2021-2032
  • Figure 153: Mexico Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 154: Mexico Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 155: Mexico Human Identification Market (by Product), $Million, 2021-2032
  • Figure 156: Rest-of-Latin America Human Identification Market, 2021-2032
  • Figure 157: Rest-of-Latin America Human Identification Market (by Technology), $Million, 2021-2032
  • Figure 158: Rest-of-Latin America Human Identification Market (by Offering), $Million, 2021-2032
  • Figure 159: Rest-of-Latin America Human Identification Market (by Product), $Million, 2021-2032
  • Figure 160: Rest-of-the-World Human Identification Market, $Million, 2021-2032
  • Figure 161: Total Number of Companies Profiled
  • Figure 162: Abbott.: Overall Product Portfolio
  • Figure 163: Abbott.: Overall Financials, $Million, 2019-2021
  • Figure 164: Abbott.: Revenue (by Segment), $Million, 2019-2021
  • Figure 165: Abbott.: Revenue (by Region), $Million, 2019-2021
  • Figure 166: Abbott.: R&D Expenditure, $Million, 2019-2021
  • Figure 167: Agilent Technologies, Inc.: Overall Product Portfolio
  • Figure 168: Agilent Technologies, Inc.: Overall Financials, $Million, 2019-2021
  • Figure 169: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 170: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 171: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2019-2021
  • Figure 172: Bio-Rad Laboratories, Inc.: Overall Product Portfolio
  • Figure 173: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2019-2021
  • Figure 174: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 175: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 176: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021
  • Figure 177: Eurofins Scientific: Product Portfolio
  • Figure 178: Eurofins Scientific: Overall Financials, $Million, 2019-2021
  • Figure 179: Eurofins Scientific: Revenue (by Region), $Million, 2019-2021
  • Figure 180: Promega Corporation.: Product Portfolio
  • Figure 181: Illumina, Inc.: Product Portfolio
  • Figure 182: Illumina, Inc.: Overall Financials, $Million, 2019-2021
  • Figure 183: Illumina, Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 184: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 185: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021
  • Figure 186: Laboratory Corporation of America Holdings: Overall Product Portfolio
  • Figure 187: Laboratory Corporation of America Holdings: Overall Financials, $Million, 2019-2021
  • Figure 188: Laboratory Corporation of America Holdings: Revenue (by Segment), $Million, 2019-2021
  • Figure 189: Laboratory Corporation of America Holdings: Revenue (by Region), $Million, 2019-2021
  • Figure 190: PerkinElmer Inc.: Product Portfolio
  • Figure 191: PerkinElmer Inc.: Overall Financials, $Million, 2019-2021
  • Figure 192: PerkinElmer Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 193: PerkinElmer Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 194: PerkinElmer Inc.: R&D Expenditure, $Million, 2019-2021
  • Figure 195: QIAGEN N.V.: Overall Product Portfolio
  • Figure 196: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
  • Figure 197: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
  • Figure 198: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
  • Figure 199: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
  • Figure 200: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 201: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
  • Figure 202: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 203: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 204: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
  • Figure 205: Verogen, Inc.: Product Portfolio
  • Figure 206: NMS Labs: Product Portfolio
  • Figure 207: AUTOGEN INC. Product Portfolio
  • Figure 208: GENETEK BIOPHARMA GmbH: Product Portfolio
  • Figure 209: SecuriGene Technologies Inc.: Product Portfolio

List of Tables

  • Table 1: COVID-19 Impact on Global Human Identification Market
  • Table 2: Products Launched by Various Key Players for Human Identification Research
  • Table 3: The following table indicates an underlying dominance of product launches and technologies that took place from 2021.Product Development, 2021
  • Table 4: Key Players and Its Products
  • Table 5: Pricing List of Key Players' Human Identification
  • Table 6: Key Players and Its Products
  • Table 7: Some of Companies Providing Products
  • Table 8: Some of Companies Providing DNA Amplification Kit
  • Table 9: Some of Companies Providing DNA Quantification Kit
  • Table 10: Some of Companies Providing DNA Extraction Kit
  • Table 11: Some of Companies Providing DNA Collection System
  • Table 12: Some of Companies Providing Electrophoresis System
  • Table 13: Some of Companies Providing Thermal Cycler
  • Table 14: Some of Companies Providing Rapid DNA Analysis System
  • Table 15: Some of Companies Offering NGS Platform
  • Table 16: Some of Companies Providing Microarray Scanner
  • Table 17: Some of Companies Providing Software
  • Table 18: Some of Companies Providing Service
  • Table 19: Example of Products Based on Next-Generation Sequencing
  • Table 20: Example of Products Based on SNP and STR Sequencing
  • Table 21: Example of Products Based on mtDNA Sequencing
  • Table 22: List of Products Based on Digital PCR
  • Table 23: Examples of Products Based on Real-Time PCR
  • Table 24: List of Products Based on Capillary Electrophoresis
  • Table 25: Example of Products Providing Nucleic Acid Extraction and Purification (Based on Magnetic Bead Technology)
  • Table 26: List of Products Based on Rapid DNA Analysis Technology
  • Table 27: List of Service Based on Other Technologies
目次
Product Code: BHP1223SA

“Global Human Identification Market to Reach $6,435.6 Million by 2032.”

Industry Overview

The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032. The growth in the global human identification market is expected to be driven by the increasing adoption of NGS in various research fields, high adoption of forensic applications, and technological advancements in the field of molecular techniques and diagnostics tests.

Market Lifecycle Stage

Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, among other applications, with DNA analysis/profiling being a key tool in this sector. Due to increasing demands on time and resources, human identification and forensics labs are under constant pressure to increase the efficiency of their workflows without sacrificing quality. Examining the variety of biological indicators that are available to investigators illustrates the basic principles of each process in criminal investigation and paternity identification. While DNA and fingerprints are clearly the favored methods of identification, they require a prior record and verifiable baseline for comparison. Further remarkable advancements in the field of genomics, proteomics, molecular biology, data analytics, and technical engineering have paved the way for the development of advanced NGS-based technologies, such as SNP and STR sequencing. The impressive research on molecular technologies and biomarkers using NGS has unlocked pathways for the development of various momentous procedures such as mtDNA sequencing. The growing demand for non-invasive diagnostic procedures enabling genetic profiling has further enhanced the requirement for NGS technologies. Acknowledging the future potential for massive growth in demand for non-invasive diagnostic procedures, several biotechnology companies such as Illumina, Inc., Thermo Fisher Scientific, and Agilent Technologies, Inc. have invested substantially to aid further developments in forensics technologies.

Impact

  • Increasing demand for human identification products/technologies is anticipated to support the growth of the global human identification market during the forecast period 2022-2032.
  • The market is expected to grow at a significant growth rate due to opportunities such as the high adoption of forensic applications in the field of computational biology and technological advancements in the field of molecular techniques and diagnostics tests.

Impact of COVID-19

The current global human identification market comprises various applications such as forensic applications, paternity applications, and other applications. It has been noticed that there has been a reduction in the capacity or shutdowns of laboratories and other research institutions, which has led to reduced usage of various products and services related to research.

The government imposed various restrictions during COVID-19, such as travel bans, quarantines, curfews, business shutdowns, and closures. This led to an increased cost of the COVID-19-related services. There have been many issues during the COVID-19 pandemic, such as operational failures, shipping issues, inaccurate demand forecasts, and other production issues.

Furthermore, the health and the safety of employees were impacted as COVID-19 reduced the efficacy of employees' work potential. However, the market related to COVID-19 grew during the pandemic as customers were in need of testing services. Overall, the impact of COVID-19 on the market size has been low-moderate. Some market players have reported a slight decline in sales. However, financials are already on their way to recovery. The decline in revenues was mostly a result of the initial phases of the COVID-19 pandemic, which comprised complete lockdowns across countries and major cities, thus interrupting the supply chain. The timeline of impact spanned the end of the first quarter and the second quarter of 2020 for most key markets across the globe. However, the pandemic has played a key role in enhancing the growth prospects of human identification and is expected to indirectly aid in improving the market growth outlook.

Market Segmentation:

Segmentation 1: by Offering

  • Product
  • Service

The service segment held the largest share, 55.47%, of the global human identification market in 2021. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 53.00% share in 2032. The high share of the services segment is majorly due to the rising demand for human identification services in paternity testing procedures, the rising number of product launches and approval in recent years, and increasing emphasis on the adoption of human identification technologies.

Segmentation 2: by Technology

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Capillary Electrophoresis
  • Nucleic Acid Extraction and Purification (Magnetic Bead Technology)
  • Rapid DNA Analysis
  • Other Technologies

In 2021, the global human identification market (by technology) was dominated by PCR, with a massive market share of 41.00%. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 37.11% share in 2032. This is primarily due to the growing incidences of violent crime leading to growth in demand for rapid DNA analysis in forensics testing.

Segmentation 3: by Application

  • Forensic Application
  • Paternity Identification
  • Other Applications

In 2021, the global human identification market (by application) was dominated by forensic applications, with a massive market share of 61.88%. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 62.11% share in 2032.

Segmentation 4: by End User

  • Forensic Laboratories and Law Enforcement Agencies
  • Academic and Research Institutions
  • Hospitals and Healthcare Providers

The forensic laboratories and law enforcement agencies segment dominate the global human identification market. Academic and research institutions are among the primary end-users of human identification. Research organizations constitute integral facilities for companies as well as independent academic research facilities.

Segmentation 5: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest-of-the-World

The North America region is expected to dominate the global human identification market during the forecast period 2022-2032. North America has a high adoption rate of forensic testing kits and services. Backed by several healthcare companies working in the marketplace, the U.S. has the highest implementation of PCR, NGS, and other technologies. The North America region is expected to reach $3,526.7 million in 2032 from $737.7 million in 2021, at a CAGR of 15.07% during the forecast period.

Recent Developments in the Global Human identification Market

  • Partnership: In 2021, QIAGEN partnered with Verogen, Inc. to provide superior tools and comprehensive support for forensic biometric identification workflows in the laboratories.
  • Product Launch: In 2021, QIAGEN launched the EZ2 Connect Instrument Line that will speed the benefits of biomedical research, forensics, and clinical diagnostics.
  • Product Launch: In 2022, Promega Corporation launched Spectrum CE System for performing human identification in criminal casework and database cases in forensic laboratories.

Demand - Drivers and Limitations

Following are the demand drivers for the human identification market:

  • Increasing Demand for Human Identification Products/Technologies
  • High Adoption of Forensic Applications in the Field of Computational Biology
  • Technological Advancements in Molecular Techniques and Forensic Tests

The market is expected to face some limitations too due to the following challenges:

  • Lack of Forensic Testing Infrastructure
  • High Capital Requirement Hampering the Expansion of Global Reach

How Can This Report Add Value to an Organization?

  • Product/Innovation Strategy: Product launches and upgrades in the human identification industry are aimed at advancing the overall technologies in the market to ensure efficient detection of various applications such as forensic and paternity identification. Several companies, including Thermo Fisher Scientific Inc., and QIAGEN N.V. were involved in product innovations.
  • Competitive Strategy: Enterprises led by the market juggernauts frequently update their product portfolios with innovative and application-specific products to sustain current market competition. Moreover, a detailed competitive benchmarking of the players operating in the global human identification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

  • Abbott.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • Promega Corporation
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Verogen, Inc.
  • NMS Labs
  • AUTOGEN INC.
  • GENETEK BIOPHARMA GmbH
  • SecuriGene Technologies Inc.

Table of Contents

1 Market

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion

2 Market Scope

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Data Sources
    • 3.1.1 Primary Data Source
    • 3.1.2 Secondary Data Sources
  • 3.2 Market Estimation Model
  • 3.3 Criteria for Company Profiling

4 Market Overview

  • 4.1 Introduction
  • 4.2 Evolution in Forensic Science
  • 4.3 Approaches for Human Identification: Biological Approach
  • 4.4 Global Human Identification Market, 2022-2032
  • 4.5 COVID-19 Impact on Global Human Identification Market
    • 4.5.1 Impact on Market

5 Industry Insights

  • 5.1 Regulatory Framework
    • 5.1.1 Regulatory Framework in the U.S
      • 5.1.1.1 Guidelines Recommendation
    • 5.1.2 Regulatory Framework in the U.S. for Medical Devices
      • 5.1.2.1 Regulation Framework for Medical Devices Used in Human Identification
  • 5.2 Legal Requirements and Framework in Asia-Pacific
      • 5.2.1.1 China
      • 5.2.1.2 Japan
        • 5.2.1.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)

6 Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Increasing Demand for Human Identification Products/Technologies
    • 6.1.2 High Adoption of Data Analytics and Computational Biology in Forensic Applications in the Field of Computational Biology
    • 6.1.3 Technological Advancements in Molecular Techniques and Forensic Tests
  • 6.2 Market Challenges
    • 6.2.1 Lack of Forensic Testing Infrastructure
    • 6.2.2 High Capital Requirement Hampering the Expansion of Global Reach
  • 6.3 Market Opportunities
    • 6.3.1 Massive Scope for Adoption of NGS and Capillary Electrophoresis Based Forensic Products in Emerging Nations
    • 6.3.2 Increased Research Funding for Executing Research and Development Exercise

7 Competitive Insights

  • 7.1 Corporate Strategies
    • 7.1.1 Synergistic Activities
    • 7.1.2 Business Expansion
  • 7.2 Business Strategies
    • 7.2.1 Service/Product Launches
  • 7.3 Market Share Analysis (by Product Manufacturer)
  • 7.4 Market Share Analysis (by Service Provider)

8 Global Human Identification Market, by Offering, $Million, 2021-2032

  • 8.1 Overview
  • 8.2 Product
    • 8.2.1 Assay and Kit
      • 8.2.1.1 DNA Amplification Kit
      • 8.2.1.2 DNA Quantification Kit
      • 8.2.1.3 DNA Extraction Kit
      • 8.2.1.4 Rapid DNA Analysis Kit
    • 8.2.2 Instrument
      • 8.2.2.1 DNA Collection System
      • 8.2.2.2 Electrophoresis System
      • 8.2.2.3 Thermal Cycler
      • 8.2.2.4 Rapid DNA Analysis System
      • 8.2.2.5 NGS Platform
      • 8.2.2.6 Microarray Scanner
      • 8.2.2.7 Other Instruments
    • 8.2.3 Software
      • 8.2.3.1 Analytical Software
      • 8.2.3.2 Data Interpretation
      • 8.2.3.3 Data Storage
  • 8.3 Service

9 Global Human Identification Market, by Technology, $Million, 2021-2032

  • 9.1 Overview
  • 9.2 Next-Generation Sequencing (NGS)
    • 9.2.1 SNP and STR Sequencing
    • 9.2.2 mtDNA Sequencing
  • 9.3 Polymerase Chain Reaction (PCR)
    • 9.3.1 Digital PCR
    • 9.3.2 Real-Time PCR
  • 9.4 Capillary Electrophoresis
  • 9.5 Nucleic Acid Extraction and Purification (Magnetic Bead Technology)
  • 9.6 Rapid DNA Analysis Technology
  • 9.7 Other Technologies

10 Global Human Identification Market, by Application, $Million, 2021-2032

  • 10.1 Overview
  • 10.2 Forensic Application
    • 10.2.1 Crime and Sexual Assault Investigation
    • 10.2.2 Missing Person Investigation
    • 10.2.3 Disaster Victim Identification
    • 10.2.4 Others
  • 10.3 Paternity Identification
    • 10.3.1 Paternity and Kinship Testing
    • 10.3.2 Genetic Testing
  • 10.4 Other Application

11 Global Human Identification Market, by End User, $Million, 2021-2032

  • 11.1 Overview
    • 11.1.1 Forensic Laboratories and Law Enforcement Agencies
    • 11.1.2 Academic and Research Institutions
    • 11.1.3 Hospitals and Healthcare Providers

12 Global Human Identification Market, By Region, $Million, 2021-2032

  • 12.1 Overview
  • 12.2 North America
    • 12.2.1 U.S.
    • 12.2.2 Canada
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 France
    • 12.3.3 U.K.
    • 12.3.4 Italy
    • 12.3.5 Spain
    • 12.3.6 Rest-of-Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 South Korea
    • 12.4.6 Rest-of-Asia-Pacific
  • 12.5 Latin America
    • 12.5.1 Brazil
    • 12.5.2 Mexico
    • 12.5.3 Rest-of-Latin America
  • 12.6 Rest-of-the-World

13 Market - Company Profiles

  • 13.1 Overview
  • 13.2 Abbott.
    • 13.2.1 Company Overview
    • 13.2.2 Role of Abbott. in the Global Human Identification Market
    • 13.2.3 Key Competitors of the Company
    • 13.2.4 Financials
    • 13.2.5 Key Insights about the Financial Health of the Company
    • 13.2.6 Analyst's Perspective
  • 13.3 Agilent Technologies, Inc.
    • 13.3.1 Company Overview
    • 13.3.2 Role of Agilent Technologies, Inc. in the Global Human Identification Market
    • 13.3.3 Key Competitors of the Company
    • 13.3.4 Financials
    • 13.3.5 Key Insights about the Financial Health of the Company
    • 13.3.6 Analyst's Perspective
  • 13.4 Bio-Rad Laboratories, Inc.
    • 13.4.1 Company Overview
    • 13.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Human Identification Market
    • 13.4.3 Key Competitors of the Company
    • 13.4.4 Key Customers of the Company
    • 13.4.5 Financials
    • 13.4.6 Key Insights about the Financial Health of the Company
    • 13.4.7 Analyst's Perspective
  • 13.5 Eurofins Scientific
    • 13.5.1 Company Overview
    • 13.5.2 Role of Eurofins Scientific in the Global Human Identification Market
    • 13.5.3 Key Competitors of the Company
    • 13.5.4 Key Customers of the Company
    • 13.5.1 Business Strategies
    • 13.5.2 Financials
    • 13.5.3 Analyst's Perspective
  • 13.6 Promega Corporation
    • 13.6.1 Company Overview
    • 13.6.2 Role of Promega Corporation in the Global Human Identification Market
    • 13.6.3 Key Customers of the Company
    • 13.6.4 Key Competitors of the Company
    • 13.6.5 Business Strategies
    • 13.6.6 Analyst's Perspective
  • 13.7 Illumina, Inc.
    • 13.7.1 Company Overview
    • 13.7.2 Role of Illumina, Inc. in the Global Human Identification Market
    • 13.7.3 Key Competitors of the Company
    • 13.7.4 Financials
    • 13.7.5 Key Insights about the Financial Health of the Company
    • 13.7.6 Analyst's Perspective
  • 13.8 Laboratory Corporation of America Holdings
    • 13.8.1 Company Overview
    • 13.8.2 Role of Laboratory Corporation of America Holdings in the Global Human identification Market
    • 13.8.3 Key Competitors of the Company
    • 13.8.4 Financials
    • 13.8.5 Analyst's Perspective
  • 13.9 PerkinElmer Inc.
    • 13.9.1 Company Overview
    • 13.9.2 Role of PerkinElmer Inc. in the Global Human Identification Market
    • 13.9.3 Key Competitors of the Company
    • 13.9.4 Financials
    • 13.9.5 Key Insights about the Financial Health of the Company
    • 13.9.6 Analyst's Perspective
  • 13.1 QIAGEN N.V.
    • 13.10.1 Company Overview
    • 13.10.2 Role of QIAGEN N.V. in the Global Human Identification Market
    • 13.10.3 Key Competitors of the Company
    • 13.10.4 Key Customers of the Company
    • 13.10.5 Corporate Strategies
    • 13.10.6 Business Strategies
    • 13.10.7 Financials
    • 13.10.8 Key Insights about the Financial Health of the Company
    • 13.10.9 Analyst's Perspective
  • 13.11 Thermo Fisher Scientific Inc.
    • 13.11.1 Company Overview
    • 13.11.2 Role of Thermo Fisher Scientific Inc. in the Global Human Identification Market
    • 13.11.3 Key Customers of the Company
    • 13.11.4 Key Competitors of the Company
    • 13.11.5 Corporate Strategies
    • 13.11.6 Business Strategies
    • 13.11.7 Financials
    • 13.11.8 Key Insights about the Financial Health of the Company
    • 13.11.9 Analyst's Perspective
  • 13.12 Verogen, Inc.
    • 13.12.1 Company Overview
    • 13.12.2 Role of Verogen, Inc. in the Global Human Identification Market
    • 13.12.3 Key Competitors of the Company
    • 13.12.4 Key Customers of the Company
    • 13.12.5 Business Strategies
    • 13.12.6 Analyst's Perspective
  • 13.13 NMS Labs
    • 13.13.1 Company Overview
    • 13.13.2 Role of NMS Labs in the Global Human Identification Market
    • 13.13.3 Key Competitors of the Company
    • 13.13.4 Corporate Strategies
    • 13.13.5 Analyst's Perspective
  • 13.14 AUTOGEN INC.
    • 13.14.1 Company Overview
    • 13.14.2 Role of AUTOGEN INC. in the Global Human Identification Market
    • 13.14.3 Business Strategies
    • 13.14.4 Analyst's Perspectives
  • 13.15 GENETEK BIOPHARMA GmbH
    • 13.15.1 Company Overview
    • 13.15.2 Role of GENETEK BIOPHARMA GmbH in the Global Human Identification Market
    • 13.15.3 Analyst's Perspectives
  • 13.16 SecuriGene Technologies Inc.
    • 13.16.1 Company Overview
    • 13.16.2 Role of SecuriGene Technologies Inc. GmbH in the Global Human Identification Market
    • 13.16.3 Analyst's Perspectives